Advisors Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-899
Closed -$9.56K 1461
2022
Q4
$9.56K Sell
899
-134
-13% -$1.56K ﹤0.01% 1451
2022
Q3
$11K Sell
1,033
-26
-2% -$339 ﹤0.01% 1446
2022
Q2
$13K Sell
1,059
-1,303
-55% -$13.8K ﹤0.01% 1468
2022
Q1
$26K Buy
2,362
+1,967
+498% +$23.9K ﹤0.01% 1460
2021
Q4
$6K Buy
+395
New +$6.5K ﹤0.01% 1483

Other funds holding DVAX

Advisors Asset Management's DVAX Position: Q1 2023 in Review

Advisors Asset Management sold out of Dynavax Technologies (DVAX) in Q1 2023, closing a stake of 899 shares — an estimated $9.56K sold.

Advisors Asset Management first reported a position in DVAX in Q4 2021 and held it in 5 quarters. The position peaked at $26K in Q1 2022. 216 funds tracked by Wall St. Rank hold DVAX as of Q1 2023.

  • Advisors Asset Management reported no remaining Dynavax Technologies position as of Q1 2023 after selling out during the quarter.
  • Advisors Asset Management sold 899 Dynavax Technologies shares in Q1 2023, an estimated $9.56K.
  • Advisors Asset Management first reported a position in Dynavax Technologies in Q4 2021 and held it in 5 quarters.
  • Advisors Asset Management's Dynavax Technologies position peaked at $26K in Q1 2022.
  • 216 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2023.

Based on Advisors Asset Management's 13F filing for Q1 2023, filed 12 May 2023.